NMC Guidelines on Ethical Advertising and Public Communication, 2026
On 6 October 2026 the Ethics and Medical Registration Board of the National Medical Commission issued the Guidelines on Ethical Advertising and Public Communication by hospitals/medical institutions and Registered Medical Practitioners, and they came into force the same day with no transition period. The single most consequential change is the definition in clause 3.2: social media, sponsored, targeted, influencer-led, search-engine, platform-based, audio-visual and AI-generated communications are now expressly treated as advertising wherever their content or manner of dissemination has a promotional character. Twelve categories of conduct are prohibited under clause 8.1, including patient testimonials, before-and-after photographs, superiority claims such as “best” or “No.1”, discounts and referral benefits, lead-generation fees, fake followers or reviews, and manipulation of search rankings. Two obligations are new and immediate: every electronic media post by a doctor must transparently disclose name, qualifications, registration status and SMR or NMR registration number (Explanation III), and any compliant AI-generated promotional content must carry a source mark stating that its origin is AI (clause 7.2). Penalties escalate from a warning and mandatory ethics training to removal from the medical register for one to three years, imposed by the State Medical Council after a show-cause notice, with an appeal to the EMRB within 60 days. Using an agency, influencer or platform does not shift responsibility — clause 4.4 is explicit on that.
What exactly was issued on 6 October 2026
This is a short document with a long reach. Eight pages, five chapters, twelve numbered clauses, and a set of Explanations that carry more operational weight than the clauses they sit under. Before the analysis, the particulars — because a surprising amount of commentary in the first week got the issuing body and the commencement position wrong.
| Particular | Detail |
|---|---|
| Instrument | Guidelines on Ethical Advertising and Public Communication by hospitals/medical institutions and Registered Medical Practitioners |
| Issued by | Ethics and Medical Registration Board (EMRB), National Medical Commission, Pocket-14, Sector-8, Dwarka Phase-1, New Delhi |
| Notice number and date | No. R-13014/01/2024-Ethics, dated 06/10/2026, issued as a Public Notice |
| Signed by | Dr Raghav Langer, Secretary, National Medical Commission — digitally signed 06-10-2026 |
| Stated trigger | Writ Petition (Civil) No. 1160/2023 before the Supreme Court of India, together with the provisions of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 |
| Commencement | “The Guidelines shall come into force with immediate effect” in the Public Notice, and clause 1.2 provides that they come into force on the date of publication. No transition period, no phased application, no grandfathering of existing content |
| Structure | Chapter I Preliminary (clauses 3–6) · Chapter II Prohibition and Exemption (clause 7) · Chapter III Responsibilities and Ethical Communication Standards (clause 8) · Chapter IV Miscellaneous Do's and Don'ts (clause 9) · Chapter V Regulatory Procedure for Oversight and Enforcement (clauses 10–12) |
| Legal character | Guidelines, not regulations. Clause 2.1(f) states they provide an operational framework consistent with the NMC Act, 2019 and the 2002 Regulations without altering, overriding or derogating from any existing statutory or regulatory requirement. Clause 2.2 adds that nothing in them permits anything otherwise prohibited |
That last row matters more than it looks. These are guidelines issued under an existing regulatory framework rather than fresh statutory regulations. They do not create new offences; they tell State Medical Councils how to read conduct that was already capable of being professional misconduct under the 2002 Regulations. The practical effect is the same for anyone publishing content — clause 10 contemplates suspension and deregistration — but it explains why the enforcement route runs through the existing professional-conduct machinery rather than through a new tribunal.
The seven stated objectives
The Public Notice lists the objectives in its own words. They are worth reading closely because the enforcement questions in the grey areas will be resolved by reference to these, not by reference to a marketing team's intentions.
| Objective as stated | What it signals for interpretation |
|---|---|
| Preserve dignity of the medical profession | The oldest thread in Indian medical ethics and the one that catches tone rather than content. A factually accurate post can still be found to offend this |
| Prevent commercialization of health care | The organising idea of the whole document. Clause 8.1(ii) prohibits participation in promotional campaigns ‘giving an impression of commercialization of medical practice' — impression, not proof |
| Protect patient interest and prevent misleading medical claims | The patient-protection limb, and the one most likely to be cited in a complaint from a member of the public |
| Ensure healthcare communication remains informational, ethical and evidence-based | The permissive side. Information is explicitly contemplated as legitimate; the line is drawn at promotion |
| Align hospital advertising practices with professional standards applicable to RMPs | The closing of the institution-versus-individual gap. Hospitals could previously advertise in ways an individual doctor could not. That arbitrage is what clause 8.3 and clause 9 are aimed at |
| Promote transparency while discouraging commercialization, regulate digital healthcare promotion | The disclosure requirements in Explanations III and IV come from here, and so does the whole digital chapter |
| Ensure ethical parity across all systems of medicine | A signal that the NMC expects comparable standards across recognised systems, even though its own jurisdiction is over practitioners registered under the NMC Act |
The definition that changes everything — clause 3.2
If you read only one clause, read this one. Every other prohibition in the document depends on whether your content is an “advertisement”, and clause 3.2 is where that is decided.
The definition is deliberately broad: an advertisement means any form of communication, promotion, publicity, announcement, representation or dissemination of information in any medium, which directly or indirectly solicits, promotes or is intended to promote the professional services, reputation, skills, qualifications, achievements, facilities or commercial healthcare services of an RMP or hospital/medical institution.
Then comes the sentence that reaches into every marketing department in Indian healthcare. For the purposes of these guidelines, digital, social-media, sponsored, targeted, influencer-led, search-engine, platform-based, audio-visual, AI-generated or AI-assisted promotional communications are to be treated as advertising where their content or manner of dissemination has a promotional character.
Read “or manner of dissemination” carefully This is the phrase that will decide most borderline cases, and almost no commentary has picked it up. Content and manner are alternatives, not cumulative conditions. A post whose content is entirely factual can still be advertising if the manner of its dissemination is promotional — boosted spend behind it, a targeted audience built from an enquiry list, placement as a sponsored result, or distribution through a paid influencer. The practical consequence is uncomfortable for a marketing calendar: the same educational article can be compliant on your blog and non-compliant as a sponsored post with a “Book now” button under it. The asset did not change. The manner of dissemination did. Audit your paid distribution before you audit your content. Most hospitals will find their organic content survives this document largely intact and their paid programme does not. |
The five Explanations — where the operational rules actually live
Clause 3.2 carries five Explanations. Two of them are carve-outs that protect ordinary professional communication, two create a brand-new disclosure obligation, and one disposes of the patient-testimonial question entirely. They are the most important part of the document and they sit in a definitions clause where a casual reader will miss them.
| Explanation | What it provides | What it means in practice |
|---|---|---|
| Explanation I — the education carve-out | The discourse of information in the normal course of discharge of information to the public at large, without the same being promotional and without any intent for commercial benefit, is exempted from the definition of advertisement | This is the clause that keeps your educational content lawful. Two conditions, both of which must hold: not promotional, and no intent for commercial benefit. The second condition is subjective and is the single largest interpretive risk in the document — see the grey-areas section |
| Explanation II — the equipment and facilities carve-out | Information regarding availability or installation of equipment, technology, diagnostic facilities or services may be disseminated as factual information, provided it contains no claims of superiority, guaranteed accuracy, guaranteed outcomes, comparative claims or other misleading or unverifiable representations | You may announce that you have installed a new scanner. You may not say it is the most advanced in the city, or that it is 99% accurate. The announcement survives; the adjectives do not |
| Explanation III — the RMP disclosure block | An RMP publishing any electronic media post should transparently disclose their name, qualifications, registration status and SMR/NMR registration number | The biggest day-one operational change in the document. Every post, reel, video and thread by a doctor now needs an identity block. Most Indian doctors' social profiles do not currently carry a registration number anywhere |
| Explanation IV — the institutional disclosure block | Clinical Establishments publishing any electronic media post should transparently disclose the names of the RMP with qualifications, registration status and SMR/NMR registration number | If your hospital post features or quotes a doctor, that doctor's credentials and registration number go on the post. This changes creative templates, not just captions — build the space into the artwork |
| Explanation V — reviews and testimonials | No RMP or hospital shall solicit, purchase, procure, manipulate or cause to be published fake, paid or misleading patient reviews, ratings, testimonials, endorsements or recommendations for the promotion of medical services. An RMP shall not request or share patient testimonials, recommendations, endorsements or reviews for professional promotion on social media | Two separate rules in one Explanation, and the second is wider than the first. The first catches fake and paid reviews. The second catches genuine, unpaid, freely given testimonials too — an RMP may not request them or share them for professional promotion on social media |
Explanation V deserves a second reading because the two limbs do different work. A hospital that has never bought a fake review is still caught by the second limb if its doctors routinely reshare grateful patient messages. That practice is now expressly named, and clause 6.2 closes the obvious workaround by providing that patient consent does not by itself make permissible a testimonial that is otherwise prohibited.
This has a consequence for reputation management that almost nobody has noticed yet. The standard recommendation in every online-reputation playbook — ask satisfied patients to leave a review — is a request for a patient review for professional promotion, and it is now expressly outside what an RMP may do. Responding to reviews that arrive unprompted is a different act and is not what Explanation V addresses, but the solicitation engine at the heart of most review programmes is. We will be rewriting our own guidance on healthcare reputation management around that change rather than around the generic playbook.
Who it applies to, and what overrides what
Clause 4 sets the scope, and it contains one of the two provisions that marketing agencies and hospital boards most need to read.
| Clause | Provision | Why it matters |
|---|---|---|
| 4.1 | Applies to the professional conduct of RMPs in relation to advertising, publicity, digital communication and promotional activities, and to address the gap created due to advent of electronic media | The NMC says in terms that this is a gap-filling exercise for the digital era. That framing will be used to resolve ambiguity in favour of coverage, not exemption |
| 4.2 | For RMPs, read with the IMC (Professional Conduct, Etiquette and Ethics) Regulations, 2002 as amended and the NMC Act, 2019. In case of irreconcilable conflict, the statutory provisions and operative regulations prevail | The guidelines sit under the regulations. They cannot create a prohibition the regulations do not support — but the 2002 Regulations are already broad on advertising |
| 4.3 | For hospitals and medical institutions, read with the applicable Clinical Establishment Act or State Act. In case of irreconcilable conflict, the Clinical Establishment Act or State Act overrides these Guidelines | State law wins for institutions. A hospital's compliance position is therefore state-specific, and a national template applied across a multi-state group will be wrong somewhere |
| 4.4 | Publication through a digital platform, third party, advertising agency, influencer or other intermediary shall not, by itself, absolve an RMP or medical institution from responsibility for content which it has authorized, commissioned, sponsored, adopted or knowingly permitted | THE CLAUSE THAT CHANGES AGENCY RELATIONSHIPS. Five verbs, and ‘knowingly permitted' is the widest of them. Not knowing is a defence only until someone shows you knew |
Clause 4.4 is the provision to take to your agency this week. It does not say the agency is innocent; it says you are not automatically innocent. A hospital that approved a campaign concept and left execution to a vendor has authorised and commissioned it. A doctor who saw a clinic's promotional reel featuring them and said nothing has arguably knowingly permitted it. The mitigation is documentary: a written content policy, a named approver, and a record of what was approved and what was rejected.
The companion point, and one this programme has made before in a data-protection context, is that responsibility cannot be outsourced to a vendor — the same principle the DPDP framework applies to data processors now appears in the NMC's advertising guidelines applied to marketing intermediaries. Two regimes, one direction of travel: accountability stays with the regulated entity.
What you are still allowed to do — the permitted list
Most of the early commentary on these guidelines read as though doctors have been removed from the internet. That is not what the document says, and reading it that way produces exactly the wrong response — hospitals quietly shutting down accounts that were doing legitimate, useful public-health work. There is a substantial permitted list, and it is worth reading before the prohibitions.
| Clause | What is expressly permitted | The conditions attached |
|---|---|---|
| 5.1 | Participation in health awareness programmes, public health campaigns, academic discussions and educational content | Three conditions, all cumulative: must not promote personal practice, must not solicit patients, and must not be monetised through promotional marketing |
| 5.2 | Hoardings and billboards in public spaces let out by municipal, state transport, railway or airport authorities | Factual information in the nature of infrastructure and facilities only. Unverified or unverifiable claims are construed as for furtherance of commercial gains and prohibited |
| 8.2(i) | Research-based communication — publishing interesting case studies in reputed medical journals | The journal route is expressly preserved. Scientific publication is not advertising |
| 8.2(ii) | Formal announcements on starting practice, change of type of practice, changing address, temporary absence from duty, resumption of another practice, succeeding to another practice, and public declaration of charge | Clause 9.3 repeats this and adds the qualifier: factual, non-promotional and limited in scope. Note that publicly declaring your consultation fee is expressly permitted |
| 8.2(iii) | Lectures or talks on public health and diseases for public awareness through television, radio and electronic media, in the doctor's own name and designation | Without promoting their employer organization. This is the clause that protects the doctor who appears on a news panel or runs an educational channel |
| 8.2(iv) | Health education and general information pamphlets and brochures issued to patients visiting the clinic or hospital | No guarantee of cure, no superiority over others, no unsubstantiated claims, no misleading information |
| 8.2(v) | Greetings on days of national importance or days related to the medical profession | Must not contain advertisement of professional gains. The festival-greeting post survives, the festival-offer post does not |
| 8.3(i) and 9.1 | Hospitals may disseminate factual, objective and verifiable information on name, location, contact details, departments, facilities, equipment, services, emergency services, accreditation status, charges and other institutional information permitted by law | And a hospital website doctor directory — names, recognised qualifications, specialties, registration details and availability — is expressly regarded as a patient-information function, materially distinct from a paid or promotional advertisement |
| 7.3 Explanation | All campaigns on programmes and schemes of the Government of India and State Governments which are in larger public interest | Exempted from the guidelines entirely |
The hospital doctor-directory carve-out in clause 9.1 is more valuable than it looks and deserves to be quoted in your internal policy. It settles a question that has worried hospital marketing teams for years: whether listing your consultants with their photographs, qualifications and timings is advertising. The NMC has said it is a patient-information function and is materially distinct from paid or promotional advertisement. Keep it factual, keep it a directory, and do not let it drift into profile pages that read as sales copy — clause 8.3(ii) prohibits promotional portrayal of an individual RMP, and clause 9.2 restricts use of an RMP's photograph where it constitutes self-advertisement, solicitation or promotional publicity.
Taken together, the permitted list supports a very specific editorial posture: be a publisher of health information rather than an advertiser of your own services. That posture is compatible with a serious content programme, a large audience and real commercial benefit over time. What it is not compatible with is the campaign calendar most Indian hospitals ran in 2026 — package offers, patient success stories, festival discounts and influencer tie-ups. The strategy that survives is the one this programme has argued for in hospital marketing and patient acquisition: earn demand with information, do not manufacture it with inducement.
The twelve prohibitions in clause 8.1, with worked examples
Clause 8.1 is headed “Advertising Restrictions and Permitted Communications for RMPs” and contains twelve sub-clauses. Several of them also bind hospitals and medical institutions expressly — (ix), (x), (xi) and (xii) are drafted as “No RMP or hospital/medical institution”. Here they are in order, with what each one actually catches.
| Clause | The prohibition | A post that now fails |
|---|---|---|
| 8.1(i) | Advertisement or activities intended to create unnecessary demand for medical procedures, promote unnecessary diagnostics, or promote fear-based marketing | “One in three adults has a silent heart blockage. Book your full-body screening today.” Fear plus an unindicated test plus a call to action — all three limbs in one post |
| 8.1(ii) | Soliciting patients directly or indirectly; self-promotion of professional services; engaging any third party for marketing medical services; permitting use of name, image, voice, testimonial or endorsement; participating in promotional campaigns giving an impression of commercialization of medical practice | A doctor appearing in a clinic's paid video saying “come to us for your knee pain.” Note ‘engage any third party for marketing medical services' — this is the clause that reaches the agency retainer itself, not just the output |
| 8.1(iii) | Advertising personal achievements, professional success rates or number of patients treated, with illustrative assertions such as “Guaranteed cures”, “Best doctors”, “No.1 Specialist”, “100% success”, “painless treatment”, “Miracle treatment”, “Exclusive cure” or any other unverifiable or exaggerated claim | “10,000+ successful surgeries.” The NMC lists ‘number of patients treated' alongside the obvious superlatives — the surgery counter on most hospital websites is directly in scope |
| 8.1(iv) | Giving, directly or indirectly, any approval, recommendation, endorsement, certificate, report or statement concerning any drug, medicine, remedy, therapeutic article, apparatus, appliance, medical device, diagnostic product, health product or commercial product in advertising or publicity, in connection with name, signature, photograph, voice or professional status — whether or not consideration is received | A dermatologist's unpaid Instagram post recommending a sunscreen brand. ‘Whether or not monetary or other consideration is received' removes the usual defence that it was not a paid partnership |
| 8.1(v) | Publishing cases for promotional purposes, advertising surgical results, displaying “before and after” photographs, publicising celebrity patients, promoting personal success stories — unless published strictly for scientific or educational purposes with anonymized patient consent | The entire aesthetic, dermatology, bariatric, orthodontic and hair-transplant content category. The exception is narrow and cumulative: strictly scientific or educational, and anonymized, and consented |
| 8.1(vi) | Statements creating unrealistic expectations, misrepresenting treatment outcomes, concealing risks, promoting unproven therapies, secret remedies or treatments whose composition, scientific basis, safety or efficacy is not adequately established | “Walk the same day after knee replacement.” Concealing risks is an omission offence — a true claim can fail this clause because of what it leaves out |
| 8.1(vii) | Offering, paying, soliciting, receiving or participating in any commission, rebate, bonus, gift, gratuity, referral fee, lead-generation fee or other consideration in relation to the promotion or advertisement of medical services, where connected with referral, recommendation or procurement of patients, specimens or materials | ‘Lead-generation fee' is named expressly. Any pay-per-lead or cost-per-acquisition arrangement with a digital agency or aggregator for patient enquiries is directly in scope |
| 8.1(viii) | Engagement of advertising agencies, digital marketing agencies, influencers or online platforms shall not be structured in a manner that results in payment or consideration being linked to the procurement or referral of individual patients | This does not ban agencies. It bans a commercial model. A monthly retainer for content and media management is a different thing from a per-patient bounty, and the document distinguishes them precisely |
| 8.1(ix) | Comparative claims such as “best”, “No.1”, “leading”, “most trusted”, “top”, “number one”, “unmatched” or similar superiority claims, unless objectively verifiable, based on a transparent and independently ascertainable methodology and otherwise permissible | Any ranking or award relied on in advertising must be capable of independent verification, with material conditions, methodology, relevant date and details of the awarding organisation disclosed where necessary. The paid ‘Best Hospital' award plaque is the specific target |
| 8.1(x) | Discounts, limited-period offers, contests, coupons, gifts, cashbacks, referral benefits, free procedures or similar inducements in a manner likely to encourage unnecessary medical consultation, diagnostic investigation or treatment, or otherwise amounting to solicitation | “Flat 40% off all health check packages this Diwali.” But note the saving provision: any lawful disclosure of charges, packages or fees shall be factual, transparent and not misleading. Publishing your package price is fine. Discounting it as an offer is not |
| 8.1(xi) | Using or permitting any celebrity, influencer, patient, employee or third party to promote professional services through prohibited testimonials, endorsements or recommendations; and using a third party as an intermediary to do indirectly what the RMP or institution is prohibited from doing directly | The anti-avoidance clause. It also requires that any material commercial relationship in lawful public-health or informational communication be transparently disclosed in accordance with applicable law |
| 8.1(xii) | Procuring or manipulating, or causing any third party to procure or manipulate, fake followers, likes, reviews, ratings, testimonials, comments, views or other digital engagement; or manipulating search rankings, visibility or algorithms to create a misleading impression of professional standing | Two different things in one clause. Buying followers is obvious. ‘Manipulate search rankings, visibility or algorithms to create a misleading impression' is not obvious at all, and the SEO section below unpacks it |
Two of the twelve deserve a note on what they do not prohibit. Clause 8.1(vii) ends payment for referrals, but it does not end referral programmes — the lawful alternatives, and the evidence on what referring doctors actually value, are the subject of our analysis of referral programmes without referral fees. And clause 8.1(xii) is not, despite a good deal of early reporting, a prohibition on search engine optimisation.
Clause 8.1(xii) and SEO — what is actually prohibited
This sub-clause caused the most confusion in the first week, with several reports suggesting that search engine optimisation itself is now banned for hospitals. It is not, and reading it that way would be both wrong and commercially damaging. The clause prohibits manipulating search rankings, visibility or algorithms to create a misleading impression of professional standing. The object of the manipulation is the misleading impression, not the ranking.
| Practice | Position under clause 8.1(xii) | Reasoning |
|---|---|---|
| Publishing genuinely useful content that ranks because it is useful | Not prohibited | No manipulation and no misleading impression. This is simply being a good publisher, which clause 5.1 and Explanation I expressly contemplate |
| Technical SEO — site speed, structured data, internal linking, clean information architecture | Not prohibited | Making accurate information findable is not creating a misleading impression of professional standing. Structured data that accurately describes your organisation is the opposite of manipulation |
| Buying followers, likes, views, comments or reviews | Expressly prohibited | Named in terms in the clause |
| Review-gating — soliciting reviews only from satisfied patients | Prohibited on two counts | Explanation V bars an RMP requesting patient reviews for professional promotion, and the selective solicitation creates a misleading impression under 8.1(xii) |
| Paid placement at the top of a doctor-listing platform | Prohibited, and at the platform level too | Clause 9.4 requires healthcare platforms hosting RMPs to prohibit paid ranking of doctors and maintain transparency in listing practices |
| Private blog networks, link buying, doorway pages, cloaking | Prohibited | Classic search manipulation, and the misleading impression of professional standing follows directly from artificially inflated authority |
| Keyword-stuffed location pages claiming ‘best hospital in [city]' | Prohibited — but under 8.1(ix), not 8.1(xii) | The superiority claim is the violation. It would be equally prohibited on a billboard |
| Paid search advertising for factual service information | Not addressed in terms, and the manner-of-dissemination test in clause 3.2 applies | The safest reading: paid distribution converts the asset into advertising, so the asset must itself satisfy the prohibitions. A compliant ad is still an ad and must be compliant as one |
The short version for a marketing head: earning visibility is not manipulation, buying the appearance of standing is. A content programme built on accurate, useful, well-structured information is not only permitted but is the posture the document points you toward. What ends is the part of the discipline that was about simulating reputation rather than building it.
Artificial intelligence — clause 7.2 and the source mark
This is the first Indian medical-regulatory instrument to place direct obligations on AI-generated promotional content, and it is unusually specific. Clause 3.3 defines AI as a self-learning automated process, program, machine or computer built for doing a task which usually requires a human brain — a broad definition that will cover generative writing and image tools without argument.
| Provision | What it requires | What to do about it |
|---|---|---|
| 7.2, first limb | AI-generated promotional campaign for furtherance of commercial interest is prohibited | Read strictly, this bars using generative AI to produce a commercial promotional campaign at all. The safe operating position is that AI may assist with research, drafting and production of information content, and must not be the engine of a commercial promotional campaign |
| 7.2, second limb | Any AI-generated promotional content conforming to the guidelines shall compulsorily carry the source mark, explicitly stating that the origin of the content is AI | A visible label, not a metadata tag. Build it into your creative templates now: a short line such as ‘This content was generated with the assistance of AI' placed where a reader will see it |
| 7.2(a) | AI-generated or AI-assisted content shall not be used to create or disseminate misleading, deceptive or unverifiable representations concerning diagnosis, treatment, clinical outcomes, professional qualifications, patient experiences or healthcare services | The hallucination clause, in effect. Any AI-drafted clinical content needs a named clinical reviewer before publication, and the review needs to be recorded |
| 7.2(b) | AI shall not be used to create or manipulate a patient's image, testimonial, voice or clinical outcome, or to create a synthetic endorsement or representation purporting to be that of an actual patient, RMP or other person | Synthetic patients and voice clones of your own consultants are out. Note it covers manipulation of a real patient's image as well as fabrication of a fictional one |
| 7.2(c) | Where AI-generated or materially AI-altered content is used in a manner in which its artificial nature may reasonably be material to the audience's understanding, appropriate disclosure shall be made | A materiality test layered on top of the blanket source-mark rule. If a viewer would read the content differently knowing a machine made it, say so prominently |
| 7.2(d) | Any use of patient information as input for an AI system shall comply with applicable privacy, confidentiality, data-protection and professional-ethics requirements | This reaches well beyond marketing. Pasting a case summary into a public chatbot to draft a post is a disclosure of patient information to a third-party processor |
| 7.6 | Advertisement involving processing, publication, storage, disclosure or other use of digital personal data shall comply with the Information Technology Act, 2000 and the Digital Personal Data Protection Act, 2023 and the Rules made thereunder in 2025 | The NMC has expressly bolted the data-protection regime onto the advertising regime. The two compliance programmes are now one programme |
The source mark is the detail most teams will get wrong Clause 7.2 does not say ‘where AI was substantially used'. It says any AI-generated promotional content conforming to these guidelines shall compulsorily carry the source mark. That is an absolute obligation attached to a category, and the category is wide. In practice almost every marketing team in Indian healthcare now drafts with AI assistance somewhere in the pipeline. The workable response is a standing policy decision, made once and documented, about where your line sits — for example: content whose substantive text or imagery was machine-generated carries the mark; content where AI was used only for spell-checking, transcription or scheduling does not. Write the policy down, apply it consistently, and be able to produce it. A consistent documented standard is defensible; an ad hoc one is not. And take 7.2(d) seriously as a separate issue from marketing. It is the clause that reaches the habit of pasting patient details into a general-purpose AI tool, and the exposure there is a data-protection exposure as much as a professional-conduct one. We have written separately on healthcare data compliance for AI agents and on purpose limitation under the DPDP framework. |
Patient privacy and consent — clause 6
Clause 6 is short, and it closes the door that most healthcare marketing in India has been walking through for a decade: the belief that a signed consent form makes a patient story publishable.
| Clause | Provision | Operational consequence |
|---|---|---|
| 6.1 | Patient information, photographs, videos, medical records, clinical images, treatment details, testimonials or other identifiable information shall not be used for advertising purposes except where permitted by applicable law and the necessary consent and other safeguards have been duly complied with | The default is prohibition and the exception is narrow. Both limbs must hold: permitted by law, and consent plus safeguards |
| 6.2 | Patient consent shall not, by itself, make permissible any testimonial, endorsement, promotional patient story, before-and-after depiction, success claim or other advertising practice that is otherwise prohibited | THE MOST IMPORTANT SENTENCE IN THE CHAPTER. Consent is necessary but not sufficient. If the practice is prohibited under clause 8.1, a consent form does not revive it |
| 6.3 | Where consent is legally required it shall be specific, informed, voluntary, documented and capable of verification, and shall comply with applicable privacy and data-protection law | Five adjectives, each of which is a test. ‘Capable of verification' in particular means a consent you can produce and authenticate later, not a tick in a file |
| 6.4 | Even where disclosure is lawfully permitted, reasonable safeguards shall be adopted, and the RMP is duty bound to prevent unnecessary disclosure of names or to crop, blur, black out birth marks, identification marks or other information through which the patient may be identified | Birth marks and identification marks are named specifically. Blurring a face is not enough if a distinctive scar, tattoo or deformity remains visible |
| 7.4 | RMP or clinical establishment shall not share any patient data, such as names, faces, anomalies, etc., which can be identified publicly | A flat prohibition sitting in the prohibitions chapter, reinforcing clause 6 |
Clause 6.3's requirement that consent be documented and capable of verification is a systems requirement, not a paperwork one. A consent you cannot retrieve and authenticate two years later is not capable of verification, which makes this a question about what your record layer stores — the subject of our guide to what a hospital CRM must record. The wider consent architecture, including the data-protection regime that clause 7.6 bolts on, is covered in consent management for healthcare data.
For an aesthetic, dental or orthopaedic practice this is the clause that ends a business model. The before-and-after sequence was the whole proposition, and the document removes it except where publication is strictly for scientific or educational purposes with anonymized patient consent under clause 8.1(v). Anonymized is doing a lot of work in that sentence, and clause 6.4 tells you how much: cropping and blurring to the point where identification marks are gone. A clinical before-and-after that is genuinely anonymized is usually no longer a compelling marketing asset — which is, on any fair reading, the intended result.
Hospitals, clinical establishments and listing platforms
Chapter IV, headed “Miscellaneous Do's and Don'ts”, is where the institutional obligations sit, and it includes the single provision with the widest market effect — the ban on paid ranking of doctors.
| Clause | Provision | Who should act on it |
|---|---|---|
| 8.3(i) and 9.1 | Hospitals may advertise only factual information, limited to objective and verifiable particulars — name, contact details, departments functioning, diagnostic facilities, emergency services, accreditation status, other facilities offered and applicable fees | Marketing head. Rebuild the website's service pages against this list and delete anything that is not on it |
| 9.1, second limb | A hospital website containing a directory of its doctors with names, recognised qualifications, specialties, registration details and availability, serving a patient-information function, shall be regarded as materially distinct from a paid or promotional advertisement or inducement | Marketing head. Quote this in your policy. It protects a page you probably assumed was at risk |
| 8.3(ii) | Institutional communication shall not contain patient solicitation, inducement, comparative superiority claims, guarantees of cure or treatment outcome, unverifiable or exaggerated claims, or promotional portrayal of an individual RMP. The form, medium or frequency of communication shall not convert otherwise factual information into solicitation or promotional self-aggrandizement | Marketing head and media buyer. ‘Frequency' is remarkable — the same factual post, repeated often enough, can become solicitation |
| 9.2 | Use of the photograph or image of an RMP shall not be permitted where such use constitutes self-advertisement, solicitation or promotional publicity. Use of a self-photograph or similar publicity material on the letterhead or signboard of a consulting room or clinical establishment is governed by Regulations 6.1.1 and 6.1.2 of the IMC Regulations, 2002, and regarded as unethical conduct | Clinic owner. Check your signboard and your letterhead before you check your Instagram |
| 9.3 | An RMP may issue a formal announcement which is factual, non-promotional and limited in scope regarding starting of practice, change of address, change of practice type, temporary absence, resumption of practice, and public declaration of consultation fees | Every practitioner. This is your permitted announcement set. Anything outside it needs a different justification |
| 9.4 | All healthcare platforms hosting RMPs shall ensure compliance with NMC ethical advertising norms, prohibition of paid ranking of doctors, and maintain transparency in listing practices | Platform operators, and every hospital that buys placement on one. The obligation is placed on the platform, but clause 4.4 means the hospital that bought the placement is not insulated |
The word ‘frequency' in clause 8.3(ii) is worth pausing on, because it is the only place in the document where repetition alone can convert compliant content into a violation. A factual service announcement sent to the same audience every week starts to look like solicitation regardless of its wording — which makes communication cadence a compliance variable as well as an engagement one, and connects this clause to the cadence discipline set out in our work on patient engagement and retention.
Clause 9.4 is the sleeper provision of this document. Doctor-discovery and appointment-booking platforms in India have operated for a decade on a model in which visibility correlates with spend. The NMC has now said that platforms hosting registered practitioners must prohibit paid ranking and maintain transparency in listing practices — and because clause 4.4 attributes responsibility for content an institution has commissioned or sponsored, a hospital buying promoted placement cannot simply point at the platform's terms of service.
The practical instruction for a hospital is to audit paid placements on third-party listing platforms this month and get written confirmation from each platform about how its ranking works. That confirmation is worth having on file whatever happens next, and asking for it costs nothing.
Penalties, procedure and appeal — Chapter V
The enforcement chapter is short, and two features of it matter as much as the penalty amounts: the action is graded, and it is taken by the State Medical Council rather than by the NMC directly.
| Stage | Action contemplated under clause 10.1 | What it means |
|---|---|---|
| First violation | Warning and mandatory ethics training | A genuine first-offence ramp. The document is not written to catch a single careless post with a suspension |
| Second violation | Censure and monetary penalty | Censure is a formal record against the practitioner, not a private word |
| Third violation | Suspension of registration for 3 to 6 months | At this point the practitioner cannot practise. The commercial consequence for a clinic dependent on one consultant is total |
| Serious violation | Suspension for 6 to 12 months — the examples given are misleading cure claims, inducement for patients, and digital mass solicitation | ‘Digital mass solicitation' is named as a serious violation in its own right, not as a repeat offence. A single large campaign can land here directly |
| Repeated violations | Removal from the medical register for 1 to 3 years | The end of the ladder |
Three procedural safeguards are built in and they are worth knowing before you need them. Clause 10.1 says the graded action “may be contemplated” by the SMC concerned — permissive language, which means the grading is a framework rather than a tariff. Clause 10.2 requires that penalties be imposed only after issuing a show-cause notice and providing an opportunity to explain or clarify. Clause 10.3 requires the SMC to issue a reasoned and speaking order setting out the specific violation identified, the contentions of the defaulting RMP and the reasons for accepting or rejecting them, and the reasons and basis for imposing the penalty.
| Appeal stage | Provision | Time limit |
|---|---|---|
| First appeal | An aggrieved RMP may appeal to the Appellate Authority, that is the EMRB, NMC, under Section 30(3) of the NMC Act, 2019. The Appellate Authority examines independently and may call for records, direct a fresh assessment or seek additional opinion | 60 days |
| Second appeal | The decision on first appeal may be contested through a second appeal under Section 30(4) of the NMC Act, 2019 | 60 days from communication of the decision |
| Hospitals and institutions | Clause 11.5: penalty and appellate mechanism under the applicable Clinical Establishments Act or State Act. Where an RMP personally authorised, participated in, endorsed or was otherwise responsible for the prohibited communication, that RMP's professional conduct may separately be examined by the SMC, EMRB or NMC | As provided by the applicable state law |
The dual-exposure point every hospital board should understand Clause 11.5 creates two tracks for one campaign. The institution is dealt with under the Clinical Establishments Act or the applicable State Act. Separately, any doctor who personally authorised, participated in, endorsed or was responsible for the communication can face professional-conduct proceedings before their State Medical Council. That is a materially different risk profile from the one most hospital marketing approval processes were designed for. A medical director who signs off a campaign is not approving on behalf of the institution alone; they are putting their own registration into the approval chain. Expect sign-off behaviour to change once this is understood, and design an approval process that gives clinicians a real basis for the decision rather than a signature block at the end of a deck. One governance consequence follows immediately: the person who approves clinical marketing content should not be the person whose targets depend on it. |
GET ACTIONABLE AI AND HEALTHCARE INSIGHTS THAT HELP YOU STAY AHEAD IN A FAST-CHANGING PHARMA WORLD
Impact by stakeholder — who has to change what
The guidelines land very unevenly. Some organisations will find they need a disclosure template and little else; others will find a core part of their marketing is no longer available to them.
| Who | Severity | What changes on day one |
|---|---|---|
| Aesthetic, dermatology, dental, hair-transplant and bariatric practices | SEVERE — the business model is directly hit | Before-and-after imagery and transformation stories are prohibited under 8.1(v), and consent does not save them under 6.2. Rebuild the content proposition around procedure education, candidacy criteria, risk disclosure and recovery expectations — genuinely useful, and permitted |
| Multi-speciality hospitals and groups | HIGH | Superiority claims, surgery counters, patient success stories, package discounts and paid listing placements all need review. The doctor directory survives; the campaign calendar mostly does not |
| Individual practitioners with a public profile | MODERATE to HIGH | Add the Explanation III disclosure block to every post immediately. Stop resharing patient messages. Stop product recommendations, paid or unpaid. Educational content continues |
| Healthcare marketing agencies | HIGH — and commercial models are affected, not just creative | Clause 8.1(viii) bars payment linked to procurement or referral of individual patients. Per-lead and per-acquisition pricing for patient enquiries is no longer a safe commercial structure. Retainers for content and media management are not prohibited |
| Doctor-listing and appointment platforms | HIGH | Clause 9.4 requires them to prohibit paid ranking of doctors and maintain transparency in listing practices. Expect product changes and expect to be asked for written confirmation by hospital clients |
| Health influencers who are registered doctors | HIGH | Brand partnerships involving any drug, device, diagnostic or health product are prohibited under 8.1(iv) whether or not paid. The educational channel survives; the sponsorship model does not |
| Health influencers who are not registered doctors | LOW under this instrument — and that is the asymmetry | The NMC regulates registered practitioners. Non-medical wellness influencers fall to consumer-protection and advertising-standards regimes instead, which is a live criticism of this document |
| Pharmaceutical and device companies | MODERATE, and indirect | 8.1(iv) bars the RMP from endorsing — which removes the doctor-testimonial format from device and consumer-health launches. Scientific engagement with clinicians is a different activity and is not what this clause addresses |
| Government and public-health campaigns | NONE | Expressly exempted by the Explanation to clause 7.3, where the campaign is on a Government of India or State Government programme or scheme in larger public interest |
The four things to stop today
If you do nothing else this week, do these four. They are the highest-frequency violations in Indian healthcare marketing, they are each named expressly in the document, and all four can be stopped by a decision rather than a project.
1. Stop posting patient testimonials, success stories and before-and-after images — including the genuine ones Clause 8.1(v) prohibits publishing cases for promotional purposes, advertising surgical results, displaying before-and-after photographs, publicising celebrity patients and promoting personal success stories. Explanation V to clause 3.2 adds that an RMP shall not request or share patient testimonials, recommendations, endorsements or reviews for professional promotion on social media. Clause 6.2 then removes the consent defence in terms. What people get wrong: the assumption that a signed consent form, an unpaid and unsolicited message, or a blurred face makes it acceptable. None of the three does. The narrow exception in 8.1(v) is publication strictly for scientific or educational purposes with anonymized patient consent — and clause 6.4 requires cropping, blurring or blacking out of birth marks and identification marks, not just faces. Do this instead: publish the clinical reasoning without the patient. “How we decide whether a knee is ready for replacement” is more useful to a prospective patient than a photograph of someone else's knee, and it is squarely inside Explanation I and clause 5.1. |
2. Stop every superlative, every ranking claim and every treated-patient counter Clause 8.1(iii) names “Guaranteed cures”, “Best doctors”, “No.1 Specialist”, “100% success”, “painless treatment”, “Miracle treatment” and “Exclusive cure”, and prohibits advertising personal achievements, professional success rates or number of patients treated. Clause 8.1(ix) adds “best”, “No.1”, “leading”, “most trusted”, “top”, “number one” and “unmatched” unless objectively verifiable on a transparent and independently ascertainable methodology. What people get wrong: treating the surgery counter as a fact rather than a claim. “15,000+ procedures performed” is expressly within 8.1(iii), which names number of patients treated. The same goes for the paid ‘Best Hospital in the Region' award badge — clause 8.1(ix) requires any ranking or award relied on to be capable of independent verification, with methodology, material conditions, relevant date and the awarding organisation disclosed. Do this instead: describe capability, not rank. “We perform robotic-assisted knee replacement and our arthroplasty unit runs a dedicated rehabilitation pathway” is factual, verifiable, informative, and permitted under Explanation II and clause 9.1. |
3. Stop discounts, offers, cashbacks, referral benefits and free-procedure promotions Clause 8.1(x) prohibits discounts, limited-period offers, contests, coupons, gifts, cashbacks, referral benefits, free procedures and similar inducements in a manner likely to encourage unnecessary medical consultation, diagnostic investigation or treatment, or otherwise amounting to solicitation of patients. What people get wrong: believing that because the price is real, the promotion is factual disclosure. The clause contains its own answer: any lawful disclosure of charges, packages or fees shall be factual, transparent and not misleading. Publishing what your health-checkup package costs is permitted — clause 9.1 lists applicable fees among the factual particulars a hospital may advertise, and clause 8.2(ii)(g) permits public declaration of charge. Discounting it with a countdown timer is a different act. And note the second limb of the mischief: likely to encourage unnecessary consultation, investigation or treatment. A discount on a screening test that a healthy person does not need is the paradigm case the clause is aimed at, and it sits alongside clause 8.1(i) on promoting unnecessary diagnostics. Do this instead: publish a clear, stable price list and compete on transparency. It is permitted, it is unusual in the Indian market, and it does more for trust than a festival offer ever did. |
4. Stop paying anyone per patient — agency, influencer, platform or individual Clause 8.1(vii) prohibits offering, paying, soliciting, receiving or participating in any commission, rebate, bonus, gift, gratuity, referral fee or lead-generation fee connected with the referral, recommendation or procurement of patients, specimens or materials. Clause 8.1(viii) then closes the structural route: engagement of advertising agencies, digital marketing agencies, influencers or online platforms shall not be structured so that payment is linked to the procurement or referral of individual patients. What people get wrong: assuming this is about cash in envelopes to referring doctors. ‘Lead-generation fee' is named in the text. A performance-marketing contract priced per qualified patient enquiry is within the plain words of 8.1(vii) and 8.1(viii), however ordinary it is as a commercial arrangement in other sectors. Do this instead: restructure to a fixed retainer or a fee for defined deliverables — content produced, channels managed, media planned. Pay for work, not for patients. This is a contract amendment, not a strategy change, and it should be on your legal team's desk this month. One related caution: clause 4.4 means that if the per-patient arrangement continues and the agency's output breaches the guidelines, the hospital and the approving RMP are not insulated by the fact that a third party executed it. |
How to keep publishing without putting anything at risk
The instinctive reaction to a document like this is to go quiet — pause the social accounts, stop the blog, wait for clarity. That reaction is wrong on the regulation and wrong on the commercial position. Nothing in the guidelines requires a hospital or a doctor to withdraw from public communication. Clause 5.1 expressly contemplates health awareness programmes, public health campaigns, academic discussions and educational content, and clause 8.2(iii) expressly protects lectures and talks on public health through electronic media in the practitioner's own name.
And there is a market reason not to go quiet. The information vacuum in Indian health search is already filled by people the NMC does not regulate. If qualified clinicians withdraw, the content that remains is produced by wellness influencers, supplement sellers and unqualified advice channels — a point made forcefully by practitioners in the first week after publication, and a fair one. The right response is not silence. It is a documented operating standard.
The disclosure block — build this into every post template now
Explanation III and Explanation IV create the only genuinely new mechanical obligation in the document, and it is trivially easy to comply with once the template exists. Add it to your caption template, your video end-card and your artwork master.
| Where | What must appear | Suggested format |
|---|---|---|
| Any electronic media post by an RMP (Explanation III) | Name · qualifications · registration status · SMR or NMR registration number | “Dr [Name], [Qualifications]. Registered medical practitioner, [State] Medical Council, Reg. No. [number].” One line, end of caption or on the end card |
| Any electronic media post by a clinical establishment featuring a doctor (Explanation IV) | The names of the RMP with qualifications, registration status and SMR/NMR registration number | Same line, applied to each clinician who appears or is quoted. Build vertical space for it into the creative template, not as an afterthought in the caption |
| Any AI-generated promotional content (clause 7.2) | A source mark explicitly stating that the origin of the content is AI | “This content was generated with the assistance of AI.” Visible to the reader, not buried in metadata |
| Content where the artificial nature is material (clause 7.2(c)) | Appropriate disclosure, over and above the source mark | Place it prominently rather than in a footer — the test is the audience's understanding of the communication |
| Any lawful public-health or informational communication with a material commercial relationship (clause 8.1(xi)) | Transparent disclosure of the material commercial relationship in accordance with applicable law | State the relationship plainly at the top of the content, not in a hashtag |
One point of drafting care. The disclosure block is an identity statement, not a credential advertisement. Listing name, qualification, registration status and registration number is what Explanation III asks for; adding “20 years of experience” and “Gold Medallist” turns a compliance element into a claim under clause 8.1(iii). Keep it to exactly what the Explanation specifies.
The content decision table — what to publish, what to rewrite, what to stop
| Content type | Position | What to do |
|---|---|---|
| Condition explainers, symptom guides, treatment-option overviews | GREEN — publish freely | This is exactly what Explanation I and clause 5.1 protect. Add the disclosure block and keep publishing |
| Procedure explainers including risks, recovery and candidacy criteria | GREEN | Risk disclosure actively helps you, because clause 8.1(vi) makes concealing risks a violation. Honest content is compliant content |
| Myth-busting and public-health campaign participation | GREEN | Clause 5.1 in terms, and the highest-value content you can produce right now |
| Doctor directory and consultant profiles on your own website | GREEN | Expressly protected by clause 9.1 as a patient-information function. Keep it factual — name, qualifications, specialty, registration, availability |
| Published price lists and package contents | GREEN | Clause 9.1 lists applicable fees; clause 8.2(ii)(g) permits public declaration of charge. Factual, transparent, not misleading, and no discounting |
| New equipment and facility announcements | GREEN with care | Explanation II permits it as factual information. Delete every superiority, accuracy-guarantee and comparative claim from the copy first |
| Health-day greetings and national-day posts | GREEN | Clause 8.2(v). Must not contain advertisement of professional gains — so no offer attached to the greeting |
| Doctor talk shows, podcasts and news panels | GREEN | Clause 8.2(iii), in the practitioner's own name and designation, without promoting the employer organisation |
| Case studies | AMBER — route them correctly | Clause 8.2(i) permits research-based communication through reputed medical journals. Clause 8.1(v) permits scientific or educational publication with anonymized consent. Journal first, then discuss the published paper |
| Webinars and CME for clinical audiences | AMBER | Professional education is not patient-facing advertising, but if it is promoted to the public with a booking link the manner of dissemination test in clause 3.2 engages |
| Boosted and sponsored posts of educational content | AMBER — the manner-of-dissemination trap | Paid distribution gives the content a promotional character. The asset must then satisfy clause 8.1 as an advertisement. Audit every boosted post |
| Patient testimonials, reviews, success stories, before-and-after | RED — stop | Clause 8.1(v), Explanation V, clause 6.2. No consent-based route back |
| Superlatives, rankings, awards, treated-patient counters | RED — stop | Clause 8.1(iii) and 8.1(ix). Unless independently verifiable with disclosed methodology |
| Discounts, offers, cashbacks, contests, referral benefits | RED — stop | Clause 8.1(x) |
| Product endorsements by doctors, paid or unpaid | RED — stop | Clause 8.1(iv). ‘Whether or not monetary or other consideration is received' |
| Per-lead or per-patient commercial arrangements | RED — restructure | Clause 8.1(vii) and 8.1(viii). A contract change, this month |
| Bought followers, reviews, engagement; paid listing rank | RED — stop | Clause 8.1(xii) and clause 9.4 |
The pre-publish checklist
Seven questions. If a post passes all seven it is very likely compliant; if it fails one, fix that one rather than abandoning the post. Put this in your content management system as a required field, not in a policy document nobody opens.
- Is this information, or is it promotion? If a reader would be better informed after reading it even if they never came to us, it is information. If its only function is to make them come to us, it is promotion and clause 8.1 applies in full.
- Does it contain a superlative, a ranking, a success rate or a count of patients treated? Delete, or substitute a verifiable capability statement. “Best”, “No.1”, “leading”, “most trusted”, “top”, “unmatched”, “100%”, “guaranteed”, “painless”, “miracle”, “exclusive” — run a find on all of them.
- Does any identifiable patient appear — image, voice, story, scan, before-and-after, or a distinguishing mark? If yes, stop. If the answer is ‘yes but we have consent', clause 6.2 says that is not enough.
- Does it name, show or imply endorsement of any drug, device, diagnostic or health product? Remove it. Clause 8.1(iv) applies whether or not you were paid.
- Is there any inducement — a discount, offer, free consultation, contest, gift, cashback or referral benefit? Remove it. A price is permitted; a price reduction framed as an offer is not.
- Does it carry the disclosure block — name, qualifications, registration status and SMR/NMR number — and, if AI-generated, the source mark? Add both. These are the two obligations that are purely mechanical and therefore the two with no excuse for failure.
- How will it be distributed? If the answer involves paid promotion, influencer distribution or a targeted audience, go back to question one and answer it again as though the post were an advertisement — because under clause 3.2 it now is.
A 30-day remediation plan
The guidelines came into force immediately and apply to content that is live now, not only to content published from today. A hospital whose archive contains two years of patient testimonials has a live exposure, and the sensible response is a documented, dated clean-up rather than a panic.
| Window | Action | Why in this order |
|---|---|---|
| Days 1–3 — stop the bleeding | Pause all paid promotion of healthcare content. Pause scheduled offer and testimonial posts. Instruct the agency in writing to publish nothing new until the policy is issued | Paid distribution is the highest-risk category and the easiest to switch off. A written instruction also creates the record clause 4.4 makes valuable |
| Days 1–7 — the obvious removals | Delete or unpublish patient testimonials, before-and-after images, superlative claims, treated-patient counters, award badges you cannot substantiate, and every live offer or discount. Keep a dated log of what was removed | The log is the evidence of mitigating action. A regulator weighing a complaint treats a documented voluntary clean-up very differently from a silent one |
| Days 5–10 — the contracts | Review every agency, influencer and platform contract for payment linked to patient procurement or referral. Issue amendment requests. Request written confirmation from listing platforms about paid ranking | Clause 8.1(viii) is about contract structure, and contracts take longer to change than captions. Start early |
| Days 7–14 — the templates | Build the Explanation III and IV disclosure block into every caption template, video end-card and artwork master. Build the AI source mark into the same templates | Once the template carries it, compliance becomes the default rather than a decision made post by post |
| Days 10–20 — the policy and the approver | Write a one-page content policy mapped to clause 8.1. Name a single approver who is not carried on marketing targets. Record approvals and rejections | This is the artefact that answers clause 4.4. Authorisation and knowing permission are what attach liability, so show a controlled authorisation process |
| Days 14–25 — train the people who actually post | Front desk, social media executive, individual consultants with personal accounts, and the agency team. Use the seven-question checklist as the training spine | Most breaches will come from a well-meaning person resharing a grateful patient's message, not from a campaign. Train for that case |
| Days 20–30 — the website and the archive | Rebuild service pages against the clause 9.1 factual list. Confirm the doctor directory is a directory. Sweep the blog archive for superlatives and patient stories | Lower urgency than social because it is less visible and less complained-about, but it is where the volume of legacy non-compliance sits |
| Ongoing — monthly | Re-run the sweep, review new NMC clarifications under clause 12, and re-confirm platform listing practices | Clause 12 expressly empowers the NMC to issue clarifications, advisories, SOPs and procedural instructions. Expect the position to move |
The grey areas, and how to behave until they are clarified
No regulatory instrument of this length settles everything, and clause 12 expressly reserves the NMC's power to issue clarifications, advisories, standard operating procedures and procedural instructions. Four questions are genuinely unresolved on the face of the document, and practitioners raised all four within the first week. The honest position is to name them rather than pretend the text is clearer than it is.
| The open question | Why it is unresolved | The defensible position until clarified |
|---|---|---|
| Where does education end and promotion begin? | Explanation I turns on content being non-promotional and carrying no intent for commercial benefit. Intent is internal and unobservable, and practitioners have argued publicly that a rule should not depend on inferring a doctor's state of mind | Behave as though the test is objective. Avoid the observable markers of promotion — booking links inside educational content, offers, urgency language, paid boosting. An article that would be equally useful published anonymously is unlikely to be read as promotional |
| Does ‘monetized through promotional marketing' in clause 5.1 catch a doctor's own channel revenue? | The phrase is not defined. It could mean monetising the content with promotional advertising, or it could reach platform revenue on an educational channel | The narrower reading is more plausible: the mischief is promotional marketing attached to the education, not the existence of channel revenue. But if you run a monetised channel, keep the promotional inventory off it and keep your own services out of it |
| How much AI assistance triggers the source mark? | Clause 7.2 attaches the obligation to ‘any AI generated promotional content' without a materiality threshold, while 7.2(c) separately imposes disclosure where artificiality is material | Adopt a written internal threshold and apply it consistently. Substantive text or imagery machine-generated: mark it. Spell-check, transcription and scheduling: do not. A documented consistent standard is defensible; improvisation is not |
| Is paid search advertising of factual information permitted? | Paid search is not named in clause 8.1, but clause 3.2 makes manner of dissemination a route into the definition of advertisement | Treat the paid asset as an advertisement and make it satisfy clause 8.1 on its own terms. Factual service information, no superlatives, no inducement, no patient content. That is a narrow but real permitted space |
There is also a structural criticism worth recording because it is likely to shape the next version. The NMC regulates registered medical practitioners. It does not regulate wellness influencers, supplement retailers or unqualified advice channels, which fall to consumer-protection and advertising-standards regimes instead. Constraining the most qualified voices in a market without equivalent constraint on the least qualified is a real risk, and practitioners said so immediately. It is an argument for clarification and for coordinated regulation, not an argument for non-compliance — the document is in force and the penalty ladder ends at deregistration.
Conclusion: the strategy that survives
Strip away the clause numbers and this document says one thing: in India, a doctor and a hospital may inform the public, and may not sell to it. Everything in Chapter III follows from that distinction, and so does the shape of the content programme that works from here.
The organisations that will struggle are the ones whose marketing was built on manufactured credibility — bought reviews, purchased awards, borrowed authority from influencers, transformation photographs, surgery counters and festival discounts. None of that is available any more, and clause 4.4 means the agency that supplied it does not absorb the consequence.
The organisations that will do well are the ones that were already publishing genuinely useful health information under their own name. For them the document is mostly an administrative exercise: add a disclosure line to the template, add a source mark where AI was used, restructure a contract, and delete a handful of legacy posts. Their core asset — accurate information published by identifiable qualified people — is precisely what clause 5.1, Explanation I and clause 8.2(iii) protect.
There is a second-order commercial point that deserves saying plainly. A regulation that removes inducement, superlatives and testimonials from a market removes the cheapest ways to compete. What is left is the expensive way: being demonstrably better and being clear about it. Over any horizon longer than a quarter that favours the serious operator, which is an unusual thing for a compliance burden to do.
And the single most common mistake in the next month will be over-correction. Going silent is not compliance; it is a strategic withdrawal from a channel your prospective patients are already using, in favour of people the NMC cannot touch. Publish more, not less — and publish the kind of content the guidelines were written to protect.
Stay ahead of the next one
Follow the Multiplier AI YouTube channel for healthcare guidance, laws and acts This is the third significant change to the rules governing Indian healthcare communication in twenty-four months, and clause 12 expressly reserves the NMC's power to issue further clarifications, advisories and standard operating procedures. The DPDP Rules, 2025 bring their substantive obligations into force in May 2027. The telecom rules on commercial communication were amended in 2025. None of these arrive with notice, and all of them land on the same marketing and operations teams. We publish plain-language breakdowns of every new healthcare guideline, law and act on the Multiplier AI YouTube channel — what changed, what it means operationally, and what to do in the first thirty days. No legalese, no fear-selling, just the working summary you can take into a Monday meeting. Subscribe to the Multiplier AI YouTube channel for all healthcare guidance, laws and acts. If this breakdown was useful, the next one will reach you on the day it matters rather than three weeks later. |
Frequently Asked Questions For NMC Ethical Advertising Guidelines 2026
They are the Guidelines on Ethical Advertising and Public Communication by hospitals/medical institutions and Registered Medical Practitioners, issued by the NMC's Ethics and Medical Registration Board under Public Notice No. R-13014/01/2024-Ethics dated 6 October 2026, in force with immediate effect. They were framed in view of Writ Petition (Civil) No. 1160/2023 before the Supreme Court and the IMC (Professional Conduct, Etiquette and Ethics) Regulations, 2002. The document has five chapters and twelve clauses, defines advertisement to include digital, social-media, influencer-led, search-engine and AI-generated promotional communication, lists twelve prohibitions in clause 8.1, and provides a graded penalty ladder running from a warning to removal from the medical register for one to three years.
Yes. Nothing in the guidelines prohibits a doctor from using social media. Clause 5.1 permits participation in health awareness programmes, public health campaigns, academic discussions and educational content, provided it does not promote personal practice, does not solicit patients and is not monetised through promotional marketing. Clause 8.2(iii) expressly permits lectures and talks on public health through electronic media in the practitioner's own name and designation. What changed is that every electronic media post must now carry a disclosure of name, qualifications, registration status and SMR/NMR registration number under Explanation III to clause 3.2, and the content must stay on the information side of the information-versus-promotion line.
Effectively yes, for promotional purposes. Explanation V to clause 3.2 provides that an RMP shall not request or share patient testimonials, recommendations, endorsements or reviews for professional promotion on social media, and bars soliciting, purchasing, procuring or manipulating fake, paid or misleading reviews. Clause 8.1(v) prohibits publishing cases for promotional purposes, advertising surgical results, before-and-after photographs, celebrity patient publicity and personal success stories. Critically, clause 6.2 provides that patient consent shall not by itself make permissible any testimonial, endorsement, promotional patient story, before-and-after depiction or success claim that is otherwise prohibited. The only route left is publication strictly for scientific or educational purposes with anonymized patient consent.
Clause 10.1 sets out a graded ladder of action that may be contemplated by the State Medical Council: warning and mandatory ethics training for a first violation; censure and monetary penalty for a second; suspension of registration for three to six months for a third; suspension for six to twelve months for a serious violation such as misleading cure claims, patient inducement or digital mass solicitation; and removal from the medical register for one to three years for repeated violations. Penalties may be imposed only after a show-cause notice and an opportunity to explain, and the SMC must issue a reasoned and speaking order. Appeal lies to the EMRB within 60 days under Section 30(3) of the NMC Act, 2019, with a second appeal under Section 30(4). Hospitals are dealt with under the applicable Clinical Establishments Act or State Act.
Only within limits, and with a visible label. Clause 7.2 prohibits AI-generated promotional campaigns for furtherance of commercial interest, and requires that any AI-generated promotional content which does conform to the guidelines shall compulsorily carry the source mark explicitly stating that the origin of the content is AI. AI may not be used to create misleading or unverifiable representations about diagnosis, treatment, outcomes, qualifications, patient experiences or services; it may not create or manipulate a patient's image, testimonial, voice or clinical outcome, or create a synthetic endorsement; and any use of patient information as input to an AI system must comply with privacy, confidentiality, data-protection and professional-ethics requirements. Clause 7.6 bolts on the Information Technology Act, 2000 and the DPDP Act, 2023 with its 2025 Rules.
No, and the guidelines say so expressly. Clause 9.1 provides that a hospital website containing a directory of its doctors — names, recognised qualifications, specialties, registration details and availability — which serves a patient-information function shall be regarded as materially distinct from a paid or promotional advertisement or inducement. Keep it a directory. Where it drifts into promotional profile pages it engages clause 8.3(ii), which prohibits promotional portrayal of an individual RMP, and clause 9.2 on use of an RMP's photograph where it constitutes self-advertisement or promotional publicity.
No. Clause 8.1(xii) prohibits procuring or manipulating fake followers, likes, reviews, ratings, testimonials, comments, views or other digital engagement, and manipulating search rankings, visibility or algorithms to create a misleading impression of professional standing. The object of the prohibition is the misleading impression. Publishing genuinely useful content that ranks because it is useful, and technical work that makes accurate information findable, are not manipulation. Buying followers or reviews, gating reviews to satisfied patients only, buying links, and paying for rank on a doctor-listing platform are all caught — and clause 9.4 separately requires healthcare platforms hosting RMPs to prohibit paid ranking of doctors.
You can retain an agency. You cannot pay it per patient. Clause 8.1(vii) prohibits any commission, rebate, bonus, gift, gratuity, referral fee or lead-generation fee connected with the referral, recommendation or procurement of patients, and clause 8.1(viii) provides that engagement of advertising agencies, digital marketing agencies, influencers or online platforms shall not be structured so that payment is linked to the procurement or referral of individual patients. A fixed retainer, or a fee for defined deliverables such as content produced and channels managed, is a different structure and is not what these clauses prohibit. Note also clause 4.4: using an agency does not by itself absolve the hospital or the RMP for content they authorised, commissioned, sponsored, adopted or knowingly permitted.
No. The Public Notice states that the guidelines shall come into force with immediate effect, and clause 1.2 provides that they come into force on the date of their publication by the NMC. There is no transition period and no grandfathering of existing published content, which is why live archives of testimonials and offers are an immediate exposure rather than a future one. The mitigating factor available to you is documented voluntary remediation — a dated log of what you removed and when, which is exactly the kind of mitigating action a reasoned order under clause 10.3 would have to weigh.
The NMC's jurisdiction is over Registered Medical Practitioners whose names are entered in the National Register under Section 31 of the NMC Act or in a State Medical Register, as clause 3.7 defines. One of the stated objectives in the Public Notice is to ensure ethical parity across all systems of medicine, but the enforcement machinery in Chapter V runs through State Medical Councils and the EMRB. Non-medical wellness influencers and unqualified advice channels fall instead to consumer-protection and advertising-standards regimes. That asymmetry is the most frequently voiced practitioner criticism of the document and a likely subject of future clarification under clause 12.
Three things, in this order, and all of them take under an hour. First, add the Explanation III disclosure block — name, qualifications, registration status, SMR or NMR number — to your profile bio and your post template. Second, delete any patient testimonial, before-and-after image or product recommendation currently live on your accounts, and keep a dated note of what you removed. Third, remove every superlative and every count of patients treated from your bio and pinned posts. Then keep publishing. Educational content under your own name is the category the guidelines were written to protect, and withdrawing from it hands the audience to people with no registration to lose.
GET ACTIONABLE AI AND HEALTHCARE INSIGHTS THAT HELP YOU STAY AHEAD IN A FAST-CHANGING PHARMA WORLD
Let's Discuss Your Requirements
